Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Intraocular Pressure Reduction with NCX 470 versus Latanoprost In Previously Treated Versus Treatment-Naïve Patients

March 5, 2024

View Press Release Corporate presentation Contact us
Previous